Control of rabies: Epidemiology of rabies in Asia and development of new-generation vaccines for rabies

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 30, Issue 5-6, 2007, Pages 273-286

  Sugiyama, Makoto ^a   Ito, Naoto ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Asia; M gene; Molecular epidemiology; N gene; Rabies virus; Reverse genetics; Vaccine

Indexed keywords

INACTIVATED VIRUS VACCINE; LIVE VACCINE; RABIES VACCINE;

ARCTIC; ARTICLE; ASIA; DRUG RESEARCH; DRUG SAFETY; GENETIC ASSOCIATION; GENETIC MANIPULATION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION CONTROL; MIDDLE EAST; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; RABIES; RABIES VIRUS; SEQUENCE ANALYSIS; SOUTH ASIA; SOUTHEAST ASIA; STRAIN DIFFERENCE; VACCINE PRODUCTION; VIRAL GENETICS; VIRUS ATTENUATION; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS MUTATION; VIRUS NUCLEOCAPSID; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ASIA; EPIDEMIOLOGY, MOLECULAR; HUMANS; RABIES; RABIES VACCINES;

RABIES VIRUS;

EID: 34548826526     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2007.05.007     Document Type: Article

References (48)

1. Knobel D.L., Cleaveland S., Coleman P.G., Fevre E.M., Meltzer M.I., Miranda M.E., et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83 (2005) 360-368
2. Kim J.H., Hwang E.K., Sohn H.J., Kim D.Y., So B.J., and Jean Y.H. Epidemiological characteristics of rabies in South Korea from 1993 to 2001. Vet Rec 157 (2005) 3-56
3. Windiyaningsih C., Wilde H., Meslin F.X., Suroso T., and Widarso H.S. The rabies epidemic on Flores Island, Indonesia (1998-2003). J Med Assoc Thai 87 (2004) 1389-1393
4. Gould A.R., Hyatt A.D., Lunt R., Kattenbelt J.A., Hengstberger S., and Blacksell S.D. Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. Virus Res 54 (1998) 165-187
5. Smith J.S., Orciari L.A., Yager P.A., Seidel H.D., and Warner C.K. Epidemiologic and historical relationships among 87 rabies virus isolates as determined by limited sequence analysis. J Infect Dis 166 (1992) 296-307
6. Kissi B., Bourhy H., and Tordo N. Genetic polymorphism in the rabies virus nucleoprotein gene. Virology 209 (1995) 526-537
7. Ito N., Sugiyama M., Oraveerakul K., Piyaviriyakul P., Lumlertdacha B., Arai Y.T., et al. Molecular epidemiology of rabies in Thailand. Microbiol Immunol 43 (1999) 551-559
8. David D., Yakobson B., Smith J.S., and Stram Y. Molecular epidemiology of rabies virus isolates from Israel and other middle and near eastern countries. J Clin Microbiol 38 (2000) 755-762
9. Arai Y.T., Takahashi H., Kameoka Y., Shiino T., Wimalaratne O., and Lodmell D.L. Characterization of Sri Lanka rabies virus isolates using nucleotide sequence analysis of nucleoprotein gene. Acta Virol 45 (2001) 327-333
10. Nishizono A., Mannen K., Elio-Villa L.P., Tanaka S., Li K.S., Mifune K., et al. Genetic analysis of rabies virus isolates in the Philippines. Microbiol Immunol 46 (2002) 413-417
11. Susetya H., Sugiyama M., Inagaki A., Ito N., Oraveerakul K., Traiwanatham N., et al. Genetic characterization of rabies field isolates from Thailand. Microbiol Immunol 47 (2003) 653-659
12. Nadin-Davis S.A., Simani S., Armstrong J., Fayaz A., and Wandeler A.I. Molecular and antigenic characterization of rabies viruses from Iran identifies variants with distinct epidemiological origins. Epidemiol Infect 131 (2003) 777-790
13. Kuzmin I.V., Botvinkin A.D., McElhinney L.M., Smith J.S., Orciari L.A., Hughes G.J., et al. Molecular epidemiology of terrestrial rabies in the former Soviet Union. J Wildl Dis 40 (2004) 617-631
14. Hyun B.H., Lee K.K., Kim I.J., Lee K.W., Park H.J., Lee O.S., et al. Molecular epidemiology of rabies virus isolates from South Korea. Virus Res 114 (2005) 113-125
15. Denduangboripant J., Wacharapluesadee S., Lumlertdacha B., Ruankaew N., Hoonsuwan W., Puanghat A., et al. Transmission dynamics of rabies virus in Thailand: implications for disease control. BMC Infect Dis 5 (2005) 52
16. Nagarajan T., Mohanasubramanian B., Seshagiri E.V., Nagendrakumar S.B., Saseendranath M.R., Satyanarayana M.L., et al. Molecular epidemiology of rabies virus isolates in India. J Clin Microbiol 44 (2006) 3218-3224
17. Smith J.S., Fishbein D.B., Rupprecht C.E., and Clerk K. Unexplained rabies in three immigrants in the United States. A virologic investigation. N Engl J Med 324 (1991) 204-211
18. Toro G., Vergara I., and Rom G. Neuroparalytic accidents of antirabies vaccination with suckling mouse brain vaccine. Clinical and pathologic study of 21 cases. Arch Neurol 34 (1977) 694-700
19. Javier R.S., Kunishita T., Koike F., and Tabira T. Semple rabies vaccine: presence of myelin basic protein and proteolipid protein and its activity in experimental allergic encephalomyelitis. J Neurol Sci 93 (1989) 221-230
20. Morimoto K., McGettigan J.P., Foley H.D., Hooper D.C., Dietzschold B., and Schnell M.J. Genetic engineering of live rabies vaccines. Vaccine 19 (2001) 3543-3551
21. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., et al. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 76 (2002) 3374-3381
22. Shoji Y., Inoue S., Nakamichi K., Kurane I., Sakai T., and Morimoto K. Generation and characterization of P gene-deficient rabies virus. Virology 318 (2004) 295-305
23. Ito N., Sugiyama M., Yamada K., Shimizu K., Takayama-Ito M., Hosokawa J., et al. Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine starain. Microbiol Immunol 49 (2005) 971-979
24. Mansfield K.L., Racloz V., McElhinney L.M., Marston D.A., Johnson N., Ronsholt L., et al. Molecular epidemiological study of Arctic rabies virus isolates from Greenland and comparison with isolates from throughout the Arctic and Baltic regions. Virus Res 116 (2006) 1-10
25. Winkler W.G., and Baer G.M. Rabies immunization of red foxes (Vulpes fulva) with vaccine in sausage baits. Am J Epidemiol 103 (1976) 408-415
26. Black J.G., and Lawson K.F. The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Can J Comp Med 44 (1980) 169-176
27. Schumacher C.L., Coulon P., Lafay F., Bnjean J., Aubert M.F., Barrat J., et al. SAG-2 oral rabies vaccine. Onderstepoort J Vet Res 60 (1993) 459-462
28. Esh J.B., Cunningham J.G., and Wiktor T.J. Vaccine-induced rabies in four cats. J Am Vet Med Assoc 180 (1982) 1336-1339
29. Whetstone C.A., Bunn T.O., Emmons R.W., and Wiktor T.J. Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox. J Am Vet Med Assoc 185 (1984) 285-288
30. Schnell M.J., Mebatsion T., and Conzelmann K.K. Infectious rabies viruses from cloned cDNA. EMBO J 13 (1994) 4195-4203
31. Faber M., Pulmanausahakul R., Nagao K., Prosniak M., Rice A.B., Koprowski H., et al. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci USA 101 (2004) 16328-16332
32. Ito N., Takayama M., Yamada K., Sugiyama M., and Minamoto N. Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. J Virol 75 (2001) 9121-9128
33. Inoue K., Shoji Y., Kurane I., Iijima T., Sakai T., and Morimoto K. An improved method for recovering rabies virus from cloned cDNA. J Virol Methods 107 (2003) 229-236
34. Yamada K., Ito N., Takayama-Ito M., Sugiyama M., and Minamoto N. Multigenic relation to the attenuation of rabies virus. Microbiol Immunol 50 (2006) 25-32
35. Shimizu K, Ito N, Mita T, Yamada K, Hosokawa-Muto J, Sugiyama M, et al. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res 2006, published on line.
36. Pulmanausahakul R., Faber M., Morimoto K., Spitsin S., Weihe E., Hooper D.C., et al. Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity. J Virol 75 (2001) 10800-10807
37. Faber M., Bette M., Preuss M.A., Pulmanausahakul R., Rehnelt J., Schnell M.J., et al. Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J Virol 79 (2005) 15405-15416
38. Dietzschold B., Wunner W.H., Wiktor T.J., Lopes A.D., Lafon M., Smith C.L., et al. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80 (1983) 70-74
39. Seif I., Coulon P., Rollin P.E., and Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 53 (1985) 926-934
40. Tuffereau C., Leblois H., Bnjean J., Coulon P., Lafay F., and Flamand A. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172 (1989) 206-212
41. Mebatsion T. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein. J Virol 75 (2001) 11496-11502
42. Faber M., Pulmanausahakul R., Hodawadekar S.S., Spitsin S., McGettigan J.P., Schnell M.J., et al. Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J Virol 76 (2002) 3374-3381
43. Shoji Y., Inoue S., Nakamichi K., Kurane I., Sakai T., and Morimoto K. Generation and characterization of P gene-deficient rabies virus. Virology 318 (2004) 295-305
44. Brzzka K., Finke S., and Conzelmann K.K. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79 (2005) 7673-7681
45. Vidy A., Chelbi-Alix M., and Blondel D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol 79 (2005) 14411-14420
46. Ito N., Takayama-Ito M., Yamada K., Hosokawa J., Sugiyama M., and Minamoto N. Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47 (2003) 613-617
47. Ito N., Sugiyama M., Yamada K., Shimizu K., Takayama-Ito M., Hosokawa J., et al. Characterization of M gene-deficient rabies virus with advantages of effective immunization and safety as a vaccine strain. Microbiol Immunol 49 (2005) 971-979
48. Mebatsion T., Weiland F., and Conzelmann K.K. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73 (1999) 242-250